Vault-13

GALERA THERAPEUTICS INC

COM · CUSIP 36338D108

41 institutional holders +8 vs Q4 2022
18,723,90518.7m shares reported held*
$54.4mreported value*
13 new 12 added 5 reduced 5 sold out net bought ≈ $17.3m (+6.7m shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $2.91. Options: 6 managers hold calls ($8.4m notional), 5 hold puts ($85.6k).

Trends to Q1 2023

Institutional holders

Managers reporting a position, each quarter

0204060Q3 22: 34Q4 22: 33Q1 23: 4141Q3 22Q4 22Q1 23
Numbers
QuarterHolders
Q3 202234
Q4 202233
Q1 202341

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
40040Q4 22: 9 bought or addedQ4 22: 15 cut or sold outQ4 22Q1 23: 25 bought or addedQ1 23: 10 cut or sold outQ1 23
Numbers
QuarterBought or addedCut or sold out
Q4 2022915
Q1 20232510

Calls vs puts

Options held, notional value, last 4 quarters. P/C = puts ÷ calls

CallsPuts
$0$2.5m$5m$7.5m$10mQ3 22 calls: $446.0kQ3 22 puts: $0Q3 22P/C 0.00Q4 22 calls: $78.7kQ4 22 puts: $1.3kQ4 22P/C 0.02Q1 23 calls: $8.4mQ1 23 puts: $85.6kQ1 23P/C 0.01
Numbers
QuarterCallsPutsP/C
Q3 2022$446.0k$00.00
Q4 2022$78.7k$1.3k0.02
Q1 2023$8.4m$85.6k0.01

Biggest buyers

Alyeska Investment Group, L.P. New +2,852,651+2.9m
Velan Capital Investment Management LP New +1,000,000+1.0m
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) New +713,531+713.5k
VANGUARD GROUP INC Added +547,147+547.1k
Parkman Healthcare Partners LLC New +525,000+525.0k
SECTORAL ASSET MANAGEMENT INC Added +431,899+431.9k
MARSHALL WACE, LLP New +182,669+182.7k
RENAISSANCE TECHNOLOGIES LLC Added +161,000+161.0k
Schonfeld Strategic Advisors LLC New +136,100+136.1k
MIRABELLA FINANCIAL SERVICES LLP New +57,000+57.0k

Biggest sellers

BRIDGEWAY CAPITAL MANAGEMENT, LLC Reduced -100,000-100.0k
SIMPLEX TRADING, LLC Sold out -34,981-35.0k
HSBC HOLDINGS PLC Sold out -11,901-11.9k
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC Sold out -10,186-10.2k
GROUP ONE TRADING LLC Sold out -3,413-3.4k
SUSQUEHANNA INTERNATIONAL GROUP, LLP Reduced -1,175-1.2k
Tower Research Capital LLC (TRC) Reduced -496-496
CITADEL ADVISORS LLC Sold out -284-284
TWO SIGMA ADVISERS, LP Reduced -100-100
GOLDMAN SACHS GROUP INC Reduced -48-48

Biggest calls

Alyeska Investment Group, L.P. New $6.4m2.5m shares
SIMPLEX TRADING, LLC Added $695.0k271.7k shares
GROUP ONE TRADING LLC Added $656.9k256.6k shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP Added $510.7k199.5k shares
CITADEL ADVISORS LLC Added $109.1k42.6k shares
CONCOURSE FINANCIAL GROUP SECURITIES, INC. Unchanged $00 shares

Biggest puts

GROUP ONE TRADING LLC New $46.1k18.0k shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP New $28.7k11.2k shares
SIMPLEX TRADING, LLC New $7.0k3.0k shares
CITADEL ADVISORS LLC Added $3.8k1.5k shares
CONCOURSE FINANCIAL GROUP SECURITIES, INC. Unchanged $00 shares

Options at notional value: the value of the shares the contracts control, as filers report them, not what the options cost. Not included in the holders, shares or buying above.

Major shareholders (over 5%)

Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.

HolderStakeChangeShares Last filed
Emerald Bioventures, LLC 13D · may seek influence +3.7 pts · filed 2026-05-29
Stated purposeItem 4 of the Original 13D is supplemented and amended, as the case may be, as follows: On May 14, 2026, the Issuer provided Emerald with a Notice of Mandatory Conversion of Series B Non-Voting Convertible Preferred Stock (the "Mandatory Conversion Notice") effective May 15, 2026 (the "Mandatory Conversion"). In connection with the Mandatory Conversion, 20,813.8186192892 shares of Series B Preferred Stock held by Emerald were converted into 20,813,818 shares of Common Stock. In lieu of fractional shares to which Emerald was entitled, the Company is required to pay Emerald an amount of cash equal to such fraction multiplied by the closing price of a share of Common Stock on the applicable Trading Market (as defined in the Certificate of Designation) on the date of the Mandatory Conversio… Full filing
 30.2% +3.7 pts 61.0m 2026-05-29
Hyare Parvinder Singh 13D · may seek influence new · filed 2026-06-11
Stated purposeThe response to Item 6 of this Schedule 13D is incorporated herein by reference. Nova MergerOn December 30, 2024, the Issuer entered into an Agreement and Plan of Merger (the "Nova Merger Agreement"), by and among the Issuer, Grape Merger Sub I, Inc., a Delaware corporation and a wholly owned subsidiary of the Issuer ("First Merger Sub"), Grape Merger Sub II, LLC, a Delaware limited liability company and wholly owned subsidiary of the Issuer ("Second Merger Sub") and Nova Pharmaceuticals, Inc., a Delaware corporation ("Nova"), on December 30, 2024 (the "Closing"), the Issuer acquired Nova. In accordance with the Nova Merger Agreement, First Merger Sub merged with and into Nova (the "First Merger"), with Nova surviving as a wholly owned subsidiary of the Issuer. Following the First Merger … Full filing
 6.7% new 13.5m 2026-06-11
CHANG NANCY T 13D · may seek influence new · filed 2026-04-10
Stated purposeThe responses to Items 3 and 6 of this Schedule 13D are incorporated herein by reference. Pursuant to the Agreement and Plan of Merger, dated December 30, 2024 (the "Merger Agreement"), by and among the Issuer, Grape Merger Sub I, Inc., a Delaware corporation and a wholly owned subsidiary of the Issuer ("First Merger Sub"), Grape Merger Sub II, LLC, a Delaware limited liability company and wholly owned subsidiary of the Issuer ("Second Merger Sub"), and Nova Pharmaceuticals, Inc., a Delaware corporation ("Nova"), on December 30, 2024 (the "Closing"), the Issuer acquired Nova. In accordance with the Merger Agreement, First Merger Sub merged with and into Nova (the "First Merger"), with Nova surviving as a wholly owned subsidiary of the Issuer. Following the First Merger and as part of … Full filing
 5.9% new 8.9m 2026-04-10

Fell to 5% or below in the last year: Ikarian Capital, LLC (0.0%, 2026-08-14)

Holders, Q1 2023

#ManagerLocationShares Value% of their portfolioChangeShares change
1 Sofinnova Investments, Inc. 0.54% of their portfolio Menlo Park, CA 3,083,7123.1m $7.9m $7.9m 0.54% Unchanged
2 Alyeska Investment Group, L.P. 0.06% of their portfolio CHICAGO, IL 2,852,6512.9m $7.3m $7.3m 0.06% New
3 NOVO HOLDINGS A/S 0.42% of their portfolio HELLERUP, G7 2,459,0212.5m $6.3m $6.3m 0.42% Unchanged
4 SECTORAL ASSET MANAGEMENT INC 1.03% of their portfolio MONTREAL, A8 2,098,5652.1m $5.4m $5.4m 1.03% Added +431.9k +431,899
5 Blackstone Inc. 0.02% of their portfolio NEW YORK, NY 1,678,9841.7m $4.3m $4.3m 0.02% Unchanged
6 VANGUARD GROUP INC 0.00% of their portfolio Valley Forge, PA 1,066,3791.1m $2.7m $2.7m 0.00% Added +547.1k +547,147
7 Velan Capital Investment Management LP 2.27% of their portfolio ALPHARETTA, GA 1,000,0001.0m $2.6m $2.6m 2.27% New
8 Tekla Capital Management LLC 0.09% of their portfolio Boston, MA 898,374898.4k $2.3m $2.3m 0.09% Unchanged
9 OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 0.04% of their portfolio CHICAGO, IL 713,531713.5k $1.8m $1.8m 0.04% New
10 Nan Fung Group Holdings Ltd 1.07% of their portfolio KAI TAK, K3 613,223613.2k $1.6m $1.6m 1.07% Unchanged
11 Parkman Healthcare Partners LLC 0.29% of their portfolio STAMFORD, CT 525,000525.0k $1.3m $1.3m 0.29% New
12 BlackRock Inc. 0.00% of their portfolio New York, NY 319,520319.5k $818.0k $818.0k 0.00% Added +22.2k +22,197
13 RENAISSANCE TECHNOLOGIES LLC 0.00% of their portfolio NEW YORK, NY 203,500203.5k $521.0k $521.0k 0.00% Added +161.0k +161,000
14 GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio BOSTON, MA 196,240196.2k $502.4k $502.4k 0.00% Added +21.3k +21,316
15 MARSHALL WACE, LLP 0.00% of their portfolio LONDON, X0 182,669182.7k $467.6k $467.6k 0.00% New
16 Ensign Peak Advisors, Inc 0.00% of their portfolio SALT LAKE CITY, UT 151,777151.8k $388.5k $388.5k 0.00% Unchanged
17 Schonfeld Strategic Advisors LLC 0.00% of their portfolio NEW YORK, NY 136,100136.1k $348.4k $348.4k 0.00% New
18 BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.01% of their portfolio HOUSTON, TX 87,00087.0k $222.7k $222.7k 0.01% Reduced -100.0k -100,000
19 STATE STREET CORP 0.00% of their portfolio BOSTON, MA 82,76482.8k $211.9k $211.9k 0.00% Added +54.0k +54,000
20 MORGAN STANLEY 0.00% of their portfolio NEW YORK, NY 57,13557.1k $146.3k $146.3k 0.00% Added +56.7k +56,744
21 MIRABELLA FINANCIAL SERVICES LLP 1.13% of their portfolio London, X0 57,00057.0k $6.7m $6.7m 1.13% New
22 LPL Financial LLC 0.00% of their portfolio FORT MILL, SC 32,23532.2k $82.5k $82.5k 0.00% New
23 NORTHERN TRUST CORP 0.00% of their portfolio CHICAGO, IL 29,26629.3k $74.9k $74.9k 0.00% Unchanged
24 Cubist Systematic Strategies, LLC 0.00% of their portfolio STAMFORD, CT 28,05628.1k $71.8k $71.8k 0.00% New
25 Raymond James Financial Services Advisors, Inc. 0.00% of their portfolio ST. PETERSBURG, FL 23,47523.5k $60.1k $60.1k 0.00% New
26 TWO SIGMA INVESTMENTS, LP 0.00% of their portfolio NEW YORK, NY 21,79121.8k $55.8k $55.8k 0.00% New
27 Virtu Financial LLC 0.01% of their portfolio New York, NY 20,19520.2k $52.0k $52.0k 0.01% New
28 JANE STREET GROUP, LLC 0.00% of their portfolio NEW YORK, NY 19,85319.9k $50.8k $50.8k 0.00% Added +9.4k +9,450
29 Tower Research Capital LLC (TRC) 0.00% of their portfolio NEW YORK, NY 17,32317.3k $44.0k $44.0k 0.00% Reduced -496 -496
30 SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.00% of their portfolio BALA CYNWYD, PA 14,00814.0k $35.9k $35.9k 0.00% Reduced -1.2k -1,175
31 TWO SIGMA ADVISERS, LP 0.00% of their portfolio NEW YORK, NY 13,10013.1k $33.5k $33.5k 0.00% Reduced -100 -100
32 GOLDMAN SACHS GROUP INC 0.00% of their portfolio NEW YORK, NY 11,31511.3k $29.0k $29.0k 0.00% Reduced -48 -48
33 ROYAL BANK OF CANADA 0.00% of their portfolio TORONTO, A6 9,8889.9k $26.0k $26.0k 0.00% Added +2.2k +2,188
34 TCI Wealth Advisors, Inc. 0.00% of their portfolio Tucson, AZ 6,2626.3k $16.0k $16.0k 0.00% Added +100 +100
35 FNY Investment Advisers, LLC 0.01% of their portfolio NEW YORK, NY 5,0005.0k $12.0k $12.0k 0.01% New
36 US BANCORP \DE\ 0.00% of their portfolio MINNEAPOLIS, MN 3,0003.0k $7.7k $7.7k 0.00% Unchanged
37 WELLS FARGO & COMPANY/MN 0.00% of their portfolio SAN FRANCISCO, CA 2,1422.1k $5.5k $5.5k 0.00% Added +2 +2
38 Federation des caisses Desjardins du Quebec 0.00% of their portfolio LEVIS, A8 2,1002.1k $5.4k $5.4k 0.00% Unchanged
39 BANK OF AMERICA CORP /DE/ 0.00% of their portfolio CHARLOTTE, NC 1,7271.7k $4.4k $4.4k 0.00% Added +767 +767
40 JPMORGAN CHASE & CO 0.00% of their portfolio NEW YORK, NY 2424 $0 $0 0.00% Unchanged
41 CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio BIRMINGHAM, AL 00 $0 $0 0.00% Unchanged